•  
  •  
  •  
  •  

2026-05-23 23:36:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores

Keywords Selected:  NeulandLaboratories

Stock Report

  • Neuland Laboratories Ltd recommends final dividend of Rs. 34
  • Neuland Laboratories Ltd consolidated Q4 FY26 PAT surges to Rs. 212.67 crores
  • Saharsh Davuluri takes over as CEO & MD of Neuland and will lead the next phase of CDMO expansion
  • Neuland Q2FY26 Total income at Rs.516.1 crore; EBITDA at Rs.156.9 crore
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Neuland Laboratories Ltd recommends final dividend of Rs. 12
  • Neuland Laboratories Ltd Q4 FY2025 consolidated net profit declines to Rs. 27.80 crores
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • Neuland Laboratories Limited transfers final part of property at Nanakramguda, Hyderabad
  • Neuland Laboratories Ltd Q2 FY2025 consolidated PAT declines to Rs. 32.84 crores
  • Neuland Laboratories Ltd Q1 FY25 consolidated PAT surges to Rs. 97.87 crores
  • Neuland unveils a refreshed brand identity
  • Neuland Laboratories Ltd recommends final dividend of Rs. 14
  • Neuland Laboratories Ltd Q4 FY2024 consolidated PAT falls to Rs. 67.56 crores
  • Neuland Laboratories Ltd's Unit 1 successfully completes USFDA inspection
  • Neuland Laboratories Ltd's promoter has sold 4 lakh shares
  • Neuland Laboratories Ltd Q1 FY2024 consolidated PAT falls QoQ to Rs. 61.87 crores
  • Neuland Laboratories Ltd gets EIR from USFDA for Unit 3
  • Neuland Laboratories Limited updates on USFDA inspection
  • Neuland Laboratories Ltd recommends final dividend of Rs. 10
  • Neuland Laboratories Ltd consolidated Q4FY23 PAT surges to Rs. 84.54 crores
  • Neuland Laboratories Ltd awarded S&P Global ESG Score, 2022
  • Neuland Laboratories Ltd consolidated Q2 FY2023 PAT jumps to Rs. 38.45 crores
  • Neuland Laboratories Ltd posts consolidated Q1FY23 PAT of Rs. 9.96 crores

Latest Post

  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025